Loading viewer...
investor_presentation
Format: PDF investor_presentation
Novo Nordisk investor presentation covering first half 2023 results, delivered at the AHA conference in Philadelphia on November 11, 2023. The presentation includes discussion of the SELECT trial, covering efficacy and safety data, as well as next steps in the company's focused healthcare strategy.
investor_presentation
13 Pages
Novo Nordisk Full Year 2020 Investor Presentation
investor_presentationinvestor_presentation
130 Pages
Novo Nordisk Full Year 2023 Investor Presentation
investor_presentationinvestor_presentation
163 Pages
investor_presentation
Viking Holdings